ViroGates Shifts Commercial Focus to Business Development, Larger Partnerships

11:25 AM EDT, 08/03/2026 (MT Newswires) -- ViroGates (VIRO.CO) unveiled a new commercial model to support its health management and longevity strategy. The Denmark-based medical technology company said Monday it will shift its commercial focus to business development with bigger and more scalable partnerships from traditional sales-led previously. Alexandre Delatour was appointed vice president of business development as part of the plan.